Latest News

11 January 2017

Evaluation of SpeeDx’s CE-marked ResistancePlus MG test for M. genitalium published in Journal of Clinical Microbiology

ResistancePlus® MG rapidly and reliably detects the disease and determines antibiotic resistance of this increasingly resistant sexually transmitted infection. SpeeDx Pty....

Read More

21 November 2016

Antibiotic Guardian Campaign aims to raise awareness of  Antibiotic Resistance in STI’s

Dr Jensen’s article highlights the problem facing us but provides a guide to potential solutions. Dr Jorgen Jensen has contributed an...

Read More

18 November 2016

SpeeDx at Australasian Sexual Health Conference 2016: The Review

SpeeDx present recent findings on theResistancePlus® MG test at the 2016 Australasian Sexual Health Conference. SpeeDx R&D Director Dr Litty Tan...

Read More

8 November 2016

Minister Opens SpeeDx Production Facility

SpeeDx had the honour of welcoming the Hon. Victor Dominello MP to officially open the new production facility in Cicada...

Read More

4 November 2016

SpeeDx Receives CE-IVD Mark for ResistancePlus™ MG

SpeeDx Pty. Ltd. has received CE-IVD marking for its ResistancePlus® MG assay that detects both the sexually transmitted disease (STD)...

Read More

5 October 2016

SpeeDx Receives TGA Approval for PlexPCR™ HSV-1&2, VZV

SpeeDx Pty. Ltd. has received TGA approval for its PlexPCR® HSV-1&2, VZV multiplex qPCR kit.  The test offers a single-well...

Read More